uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted July 31, 2020

FTC Sues Golden Sunrise for Marketing Deceptive $23,000 Coronavirus Cure

On July 31, 2020, the Federal Trade Commission (FTC) charged Golden Sunrise Nutraceutical, Inc., a California-based company, with deceptively advertising a $23,000 treatment plan as a scientifically proven way to treat COVID-19.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at